As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.
As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.
Transcript (slightly modified for readability)
Happy anniversary to AJMC, it's an important, multi-stakeholder movement, not only a high-quality journal, and I'm so pleased to be part of the board.
How has AJMC contributed to the field of managed care over the last 20 years?
AJMC has really been the sole provider of a very broad literature on managed care real-world studies, and having been a co-founder of a delivery system-based institute for outcomes research on evaluation, I really appreciate the real-world approach to the science.
It's important to have a peer-reviewed process that includes the look at methodology and statistical approaches in a real-world setting. Not all of the studies included in this broad literature are randomized trials, and that opens up a whole world of opportunity to share best practices across the nation, and the world.
How will both managed care and AJMC change in the next 20 years?
Well I think the answer to that is for both AJMC and the industry, the movement really is toward population health, improving quality, and improving value, and that means better quality for a reasonable cost and the best value for patients, who we're now referring to as consumers. And managed care is across multi-stakeholder groups: it's payers of all kinds, it's the delivery systems involved in accountable care, and it's the consumers seeking other places of care in the retail world that are really going to require a massive change in how we look at the healthcare delivery system, and moving it more into the lives of consumers and patients.
I think the group, the board, that AJMC has put together really is in a good position to continue to support its members in a way that can lead this change.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More